Cardiac metabolic remodelling in chronic kidney disease

N Patel, MM Yaqoob, D Aksentijevic - Nature Reviews Nephrology, 2022 - nature.com
Chronic kidney disease (CKD) affects millions of people globally and, for most patients, the
risk of developing cardiovascular disease is higher than that of progression to kidney failure …

Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: a focus on microcirculatory factors and therapeutic targets

J Van de Wouw, M Broekhuizen, O Sorop… - Frontiers in …, 2019 - frontiersin.org
Heart failure (HF) and chronic kidney disease (CKD) co-exist, and it is estimated that about
50% of HF patients suffer from CKD. Although studies have been performed on the …

Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease

YNV Reddy, M Obokata, PG Dean… - European heart …, 2017 - academic.oup.com
Aims Short-term studies have reported left ventricular (LV) dilatation following surgical
creation of arteriovenous fistulas (AVF) or arteriovenous grafts (AVGs), but chronic cardiac …

[HTML][HTML] Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction

RP Juni, R Al-Shama, DWD Kuster, J van der Velden… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) promotes development of cardiac abnormalities and is highly
prevalent in patients with heart failure, particularly in those with preserved ejection fraction …

End of life, withdrawal, and palliative care utilization among patients receiving maintenance hemodialysis therapy

JCY Chen, B Thorsteinsdottir, LE Vaughan… - Clinical Journal of the …, 2018 - journals.lww.com
Results Among 1226 patients, 536 died and 262 (49% of 536) withdrew. A random sample
(10%; 52 out of 536) review of Death Notification Forms revealed 73% sensitivity for …

Heart failure in end-stage kidney disease: pathophysiology, diagnosis, and therapeutic strategies

J Rangaswami, PA McCullough - Seminars in nephrology, 2018 - Elsevier
Heart failure (HF) is a major comorbidity in patients with end-stage kidney disease (ESKD).
The pathogenesis of HF in patients on renal replacement therapy represents the confluence …

[HTML][HTML] Interrelation between heart failure with preserved ejection fraction and renal impairment

JR Joslin, E Lioudaki, E Androulakis - Reviews in cardiovascular …, 2022 - imrpress.com
Heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) are
global diseases of increasing prevalence and are frequent co-diagnoses. The two …

The cardio-renal interrelationship

KD Boudoulas, F Triposkiadis, J Parissis… - Progress in …, 2017 - Elsevier
The heart and the kidney are of utmost importance for the maintenance of cardiovascular
(CV) homeostasis. In healthy subjects, hemodynamic changes in either organ may affect …

Heart disease in chronic kidney disease–review of the mechanisms and the role of dialysis access

J Malik - The journal of vascular access, 2018 - journals.sagepub.com
Cardiovascular complications are responsible not only for the high mortality, but also the
morbidity of end-stage renal disease patients. Cyclic changes of fluid load, together with the …

Tissue ischemia worsens during hemodialysis in end-stage renal disease patients

J Malik, J Kudlicka, J Lachmanova… - The journal of …, 2017 - journals.sagepub.com
Background Cognitive deficit is a common problem in end-stage renal disease (ESRD)
patients. Ultrafiltration and hemodialysis lead to profound hemodynamic changes. The aim …